Abstract Number: 235 • 2013 ACR/ARHP Annual Meeting
Meniscal Extrusion Is a Better Predictor Of Radiographic Osteoarthritis Change Over Ten Years Compared To Cartilage Volume Loss
· Background/Purpose: Change in joint space narrowing (JSN) on radiographs is currently the gold standard for monitoring disease progression of knee osteoarthritis in clinical trials…Abstract Number: 236 • 2013 ACR/ARHP Annual Meeting
Hip Bone Marrow Lesions In Asymptomatic and Osteoarthritic Adults: Prevalence, Risk Factors and Significance
Background/Purpose: Bone marrow lesions (BMLs) at the knee have an important role in the pathogenesis of osteoarthritis (OA), being associated with increased pain, accelerated cartilage…Abstract Number: 237 • 2013 ACR/ARHP Annual Meeting
The Association Of Radiographic Disease With Lesions On MRI In Lateral Compartment Knee Osteoarthritis: The Osteoathritis Initiative
Background/Purpose: Lateral compartment knee tibio-femoral radiographic osteoarthritis (ROA) is associated with pain and disability, and the epidemiology of this form of knee OA is…Abstract Number: 238 • 2013 ACR/ARHP Annual Meeting
Structural Predictors Of Ten Year Knee Cartilage Volume Loss
Background/Purpose: Cartilage volume loss is considered a key feature of knee osteoarthritis (OA) and increased loss over two years is associated with future knee replacement…Abstract Number: 239 • 2013 ACR/ARHP Annual Meeting
A Family History Of Knee Joint Replacement Increases The Progression Of Knee Joint Radiographic Osteoarthritis and Cartilage Volume Loss Over Ten Years
Background/Purpose: Osteoarthritis (OA) is a disease of multifactorial origin with a modest but significant heritable effect for disease severity in the knee joint. The aim…Abstract Number: 200 • 2013 ACR/ARHP Annual Meeting
Hydroxychloroquine Use Among Systemic Lupus Erythematosus Patients In An Academic Rheumatology Practice
Background/Purpose: Hydroxychloroquine (HCQ) is a mainstay in the current treatment of systemic lupus erythematosus (SLE). HCQ has been shown to reduce the incidence of SLE…Abstract Number: 216 • 2013 ACR/ARHP Annual Meeting
Systematic Staging For Uric Acid Deposits With Dual-Energy Computed Tomography and Ultrasound In Suspected Gout
Background/Purpose: To evaluate the diagnostic accuracy of Dual-Energy Computed Tomography (DECT) and ultrasound for detecting monosodium urate crystal deposits in patients with clinically suspected gout.…Abstract Number: 201 • 2013 ACR/ARHP Annual Meeting
Comparison To Organisational Models For EARLY Rheumatoid Arthritis Management: Routine Care Versus EARLY Arthritis Clinic
Background/Purpose: although the Early Arthritis Clinic (EAC) institution is considered the best approach for the management of rheumatoid arthritis (RA) at an early stage, to…Abstract Number: 202 • 2013 ACR/ARHP Annual Meeting
Analysis Of Non-Steroidal Anti-Inflammatory Drug Burden Among Rheumatoid Arthritis Patients Using The Dougados Algorithm
Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are used to alleviate RA pain symptoms, but they may be associated with adverse events. Previous studies examining clinical and…Abstract Number: 203 • 2013 ACR/ARHP Annual Meeting
Belief In Self-Adjustability Of Medication Dosing Is Negatively Correlated With Medication Adherence In Patients With Rheumatoid Arthritis
Background/Purpose: Medication adherence in Rheumatoid Arthritis (RA) is reported to be generally low. This major problem needs to be addressed because it leads to reduced…Abstract Number: 204 • 2013 ACR/ARHP Annual Meeting
Evaluation Of Hospitalizations and Costs In Patients With Rheumatoid Arthritis In United States Medicare Population
Background/Purpose: RA-related hospitalization and surgery (e.g. total joint arthroplasty [TJA]) are important long-term outcomes in RA. While advances in treatment for RA have resulted in…Abstract Number: 205 • 2013 ACR/ARHP Annual Meeting
Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines
Background/Purpose: Disease modifying anti-rheumatic drugs (DMARDs) are standard initial treatments for rheumatoid arthritis (RA). Many RA treatment guidelines have been published including from the American…Abstract Number: 206 • 2013 ACR/ARHP Annual Meeting
American College Of Rheumatology’s Rheumatology Informatics System For Effectiveness Registry Pilot
Background/Purpose: There is a significant need in the rheumatology community to access and integrate data across diverse patient populations in order to aid quality improvement…Abstract Number: 207 • 2013 ACR/ARHP Annual Meeting
Frequency and Predictors Of Hypertension Communication In Rheumatoid Arthritis Visits
Background/Purpose: Patients with rheumatoid arthritis (RA) have a 60% higher cardiovascular disease (CVD) event risk, yet previously we demonstrated they were ~30% less likely to…Abstract Number: 208 • 2013 ACR/ARHP Annual Meeting
Three Approaches To Evaluating Step Therapy Policies For Immune Disorder Specialty Pharmaceuticals
Background/Purpose: Rheumatology practices are increasingly exposed to patient health care benefit plans that include “step therapy” (ST) policies which affect medication choice. Managed care companies…